| 翻訳と辞書 |
| George Kollias (biologist) ： ウィキペディア英語版 |
George Kollias (biologist)
George Kollias (Greek: Γιώργος Κόλλιας; born November 9, 1958 in Athens) is a , Member of the (Academy of Athens ) and Professor of Physiology at the (Medical School ) of the University of Athens. He is renowned for providing the preclinical rationale for the development of anti-TNF therapies for rheumatoid arthritis. His research is highly cited for discovering disease pathways in animal models of chronic inflammation and autoimmunity (e.g. Rheumatoid Arthritis, Inflammatory Bowel Disease and Multiple Sclerosis).〔(Brief CV at Alexander Fleming BSRC )〕 He is credited with the development of major national infrastructures of scientific and technological excellence in Greece.
== Education and employment ==
George Kollias graduated from the Biology Department of the (University of Athens ), Greece and performed doctoral studies in Molecular Biology from 1980 to 1984 at the (National Hellenic Research Foundation ). He continued with postdoctoral research in the field of gene structure and expression at the Laboratory of Gene Structure and Expression, (National Institute for Medical Research, Mill Hill ), London, UK, and from 1990-2000 he established the Laboratory of Molecular Genetics at the (Hellenic Pasteur Institute ) in Athens, Greece. From 2000-2002, he was appointed Director of the Institute for Immunology at the (Biomedical Sciences Research Center "Alexander Fleming" ), and has served as the Center's President and Scientific Director from 2002-2010. He is currently Director of the Division of Immunology at BSRC Fleming.〔 Since May 2012, he is Professor of Experimental Physiology at the Medical School of the University of Athens.
抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』
■ウィキペディアで「George Kollias (biologist)」の詳細全文を読む
スポンサード リンク
| 翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|